BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 23210516)

  • 1. Effect of the prosthetic group on the pharmacologic properties of 18F-labeled rhodamine B, a potential myocardial perfusion agent for positron emission tomography (PET).
    Bartholomä MD; Gottumukkala V; Zhang S; Baker A; Dunning P; Fahey FH; Treves ST; Packard AB
    J Med Chem; 2012 Dec; 55(24):11004-12. PubMed ID: 23210516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (18)F-labeled rhodamines as potential myocardial perfusion agents: comparison of pharmacokinetic properties of several rhodamines.
    Bartholomä MD; Zhang S; Akurathi V; Pacak CA; Dunning P; Fahey FH; Cowan DB; Treves ST; Packard AB
    Nucl Med Biol; 2015 Oct; 42(10):796-803. PubMed ID: 26205075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodistribution and stability studies of [18F]fluoroethylrhodamine B, a potential PET myocardial perfusion agent.
    Gottumukkala V; Heinrich TK; Baker A; Dunning P; Fahey FH; Treves ST; Packard AB
    Nucl Med Biol; 2010 Apr; 37(3):365-70. PubMed ID: 20346876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological characterization of F-18-labeled rhodamine B, a potential positron emission tomography perfusion tracer.
    Bartholomä MD; He H; Pacak CA; Dunning P; Fahey FH; McGowan FX; Cowan DB; Treves ST; Packard AB
    Nucl Med Biol; 2013 Nov; 40(8):1043-8. PubMed ID: 24011396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of fluorine-18 labeled rhodamine B: A potential PET myocardial perfusion imaging agent.
    Heinrich TK; Gottumukkala V; Snay E; Dunning P; Fahey FH; Ted Treves S; Packard AB
    Appl Radiat Isot; 2010 Jan; 68(1):96-100. PubMed ID: 19783150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel synthesis and initial preclinical evaluation of (18)F-[FDG] labeled rhodamine: a potential PET myocardial perfusion imaging agent.
    AlJammaz I; Al-Otaibi B; AlHindas H; Okarvi SM
    Nucl Med Biol; 2015 Oct; 42(10):804-8. PubMed ID: 26160144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of novel gallium-68 labeled rhodamine: A potential PET myocardial perfusion agent.
    Jammaz IA; Al-Otaibi B; Al-Hokbani N; Okarvi SM
    Appl Radiat Isot; 2019 Feb; 144():29-33. PubMed ID: 30508730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and preliminary evaluation of 18F-labeled pyridaben analogues for myocardial perfusion imaging with PET.
    Mou T; Zhao Z; Fang W; Peng C; Guo F; Liu B; Ma Y; Zhang X
    J Nucl Med; 2012 Mar; 53(3):472-9. PubMed ID: 22302832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and bioevaluation of 4-chloro-2-tert-butyl-5-[2-[[1-[2-[(18) F]fluroethyl]-1H-1,2,3-triazol-4-yl]methyl]phenylmethoxy]-3(2H)-pyridazinone as potential myocardial perfusion imaging agent with PET.
    Mou T; Zhao Z; You L; Wang Q; Fang W; Lu J; Peng C; Zhang X
    J Labelled Comp Radiopharm; 2015 Jun; 58(8):349-54. PubMed ID: 26094722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of 18F-Labeled Fluoroalkylphosphonium Cations with 13N-NH3 for PET Myocardial Perfusion Imaging.
    Kim DY; Kim HS; Reder S; Zheng JH; Herz M; Higuchi T; Pyo AY; Bom HS; Schwaiger M; Min JJ
    J Nucl Med; 2015 Oct; 56(10):1581-6. PubMed ID: 26069304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of (18)F-trifluoroborate derivatives of triphenylphosphonium for myocardial perfusion imaging.
    Zhang Z; Jenni S; Zhang C; Merkens H; Lau J; Liu Z; Perrin DM; Bénard F; Lin KS
    Bioorg Med Chem Lett; 2016 Apr; 26(7):1675-9. PubMed ID: 26922139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and biodistribution of [18F]FP2OP as myocardial perfusion imaging agent for positron emission tomography.
    Mou T; Jing H; Yang W; Fang W; Peng C; Guo F; Zhang X; Pang Y; Ma Y
    Bioorg Med Chem; 2010 Feb; 18(3):1312-20. PubMed ID: 20056551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and preliminary evaluation of (18)F-labeled 4-thia palmitate as a PET tracer of myocardial fatty acid oxidation.
    DeGrado TR; Wang S; Holden JE; Nickles RJ; Taylor M; Stone CK
    Nucl Med Biol; 2000 Apr; 27(3):221-31. PubMed ID: 10832078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a novel (18)F-labeled positron-emission tomography perfusion tracer for the assessment of myocardial infarct size in rats.
    Sherif HM; Saraste A; Weidl E; Weber AW; Higuchi T; Reder S; Poethko T; Henriksen G; Casebier D; Robinson S; Wester HJ; Nekolla SG; Schwaiger M
    Circ Cardiovasc Imaging; 2009 Mar; 2(2):77-84. PubMed ID: 19808572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly efficient one-pot labeling of new phosphonium cations with fluorine-18 as potential PET agents for myocardial perfusion imaging.
    Zhao Z; Yu Q; Mou T; Liu C; Yang W; Fang W; Peng C; Lu J; Liu Y; Zhang X
    Mol Pharm; 2014 Nov; 11(11):3823-31. PubMed ID: 24852080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiosynthesis and preliminary biological evaluation of a new (18)F-labeled triethylene glycol derivative of triphenylphosphonium.
    Tominaga T; Ito H; Ishikawa Y; Iwata R; Ishiwata K; Furumoto S
    J Labelled Comp Radiopharm; 2016 Mar; 59(3):117-23. PubMed ID: 26861736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new 18F-labeled myocardial PET tracer: myocardial uptake after permanent and transient coronary occlusion in rats.
    Higuchi T; Nekolla SG; Huisman MM; Reder S; Poethko T; Yu M; Wester HJ; Casebier DS; Robinson SP; Botnar RM; Schwaiger M
    J Nucl Med; 2008 Oct; 49(10):1715-22. PubMed ID: 18794259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of ¹⁸F-labeled BODIPY dye as potential PET agents for myocardial perfusion imaging.
    Liu S; Li D; Shan H; Gabbaï FP; Li Z; Conti PS
    Nucl Med Biol; 2014 Jan; 41(1):120-6. PubMed ID: 24210284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vivo Ester Hydrolysis as a New Approach in Development of Positron Emission Tomography Tracers for Imaging Hypoxia.
    Zhang L; Yao X; Cao J; Hong H; Zhang A; Zhao R; Zhang Y; Zha Z; Liu Y; Qiao J; Zhu L; Kung HF
    Mol Pharm; 2019 Mar; 16(3):1156-1166. PubMed ID: 30676751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The next generation of cardiac positron emission tomography imaging agents: discovery of flurpiridaz F-18 for detection of coronary disease.
    Yu M; Nekolla SG; Schwaiger M; Robinson SP
    Semin Nucl Med; 2011 Jul; 41(4):305-13. PubMed ID: 21624564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.